Lobby groups dismissive of Pharmac’s medicines wait-list cull

+News

Lobby groups dismissive of Pharmac’s medicines wait-list cull

NZD

New Zealand Doctor

iceberg
While Pharmac wants to cull eight dormant drug funding applications, 100 more drugs languish waiting for approval, critics say
Pharmac’s proposed medicine funding overhaul is a PR stunt offering little action to address funding for medicines New Zealanders need, critics say. , Sarah Fitt, People want definitive funding decisions, even if a drug is declined, Pharmac chief executive Sarah Fitt says